142275-57-8 Usage
Type of compound
Chemical compound
Medical use
Treatment for certain types of lung cancer and neuroblastoma in children
Mechanism of action
Targets and inhibits specific proteins in cancer cells, slowing down or stopping cancer growth and spread
Form of administration
Oral capsules or tablets
Prescription
Often prescribed by a doctor as part of a larger treatment plan for cancer patients
Importance
Valuable medical applications in the treatment of cancer
Check Digit Verification of cas no
The CAS Registry Mumber 142275-57-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,2,2,7 and 5 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 142275-57:
(8*1)+(7*4)+(6*2)+(5*2)+(4*7)+(3*5)+(2*5)+(1*7)=118
118 % 10 = 8
So 142275-57-8 is a valid CAS Registry Number.
142275-57-8Relevant academic research and scientific papers
Aminotriazine 5-HT7 antagonists
Mattson, Ronald J.,Denhart, Derek J.,Catt, John D.,Dee, Michael F.,Deskus, Jeffrey A.,Ditta, Jonathan L.,Epperson, James,Dalton King,Gao, Aiming,Poss, Michael A.,Purandare, Ashok,Tortolani, David,Zhao, Yufen,Yang, Hua,Yeola, Suresh,Palmer, Jane,Torrente, John,Stark, Arlene,Johnson, Graham
, p. 4245 - 4248 (2007/10/03)
The present studies have identified a series of aminotriazines as novel 5-HT7 receptor antagonists. Compounds 10 and 17 have high affinity for the 5-HT7 receptor and do not bind to either the 5-HT 2C or 5-HT6 re
